LAUSR

HighlightsAcute HH induced cognitive impairments and neuroinflammation in the hippocampus.Genetic A2AR deletion attenuated acute HH‐induced impairment of spatial memory.Hippocampal A2ARs were mainly expressed on microglia and up‐regulated in acute HH model of mice.Microglia‐mediated neuroinflammation by acute HH was inhibited through genetic A2AR inactivation. ABSTRACT Hypobaric hypoxia (HH) at high altitudes leads to a wide range of cognitive impairments which can handicap human normal activities and performances. However, the underlying mechanism is still unclear. Adenosine A2A receptors (A2ARs) of the brain are pivotal to synaptic plasticity and cognition. Besides, insult‐induced up‐regulation of A2AR regulates neuroinflammation and therefore induces brain damages in various neuropathological processes. The present study was designed to determine whether A2AR‐mediate neuroinflammation involves in cognitive impairments under acute HH. A2AR knock‐out and wild‐type male mice were exposed to a simulated altitude of 8000 m for 7 consecutive days in a hypobaric chamber and simultaneously received behavioral tests including Morris water maze test and open filed test. A2AR expression, the activation of microglia and the production of TNF‐&agr; were evaluated in the hippocampus by immunohistochemistry and ELISA, respectively. Behavioral tests showed that acute HH exposure caused the dysfunction of spatial memory and mood, while genetic inactivation of A2AR attenuated the impairment of spatial memory but not that of mood. Double‐labeled immunofluorescence showed that A2ARs were mainly expressed on microglia and up‐regulated in the hippocampus of acute HH model mice. Acute HH also induced the accumulation of microglia and increased production of TNF‐&agr; in the hippocampus, which could be markedly inhibited by A2AR inactivation. These findings indicate that microglia‐mediated neuroinflammation triggered by A2AR activation involves in acute HH‐induced spatial memory impairment and that A2AR could be a new target for the pharmacotherapy of cognitive dysfunction at high altitudes.